Schaumann D - Search Results

1

FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.

Kliem V, Eberhard OK, Oldhafer K, Schlitt HJ, Behrend M, Schaumann D, Pichlmayr R, Koch KM, Brunkhorst R. Kliem V, et al. Among authors: schaumann d. Transplant Proc. 1996 Dec;28(6):3166-8. Transplant Proc. 1996. PMID: 8962227 Clinical Trial. No abstract available.

2

Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients.

Kliem V, Schaumann D, Ehlerding G, Eberhard OK, Lufft V, Schlitt HJ, Pichlmayr R, Koch KM, Brunkhorst R. Kliem V, et al. Among authors: schaumann d. Transplant Proc. 1997 Nov;29(7):2955-7. doi: 10.1016/s0041-1345(97)00743-4. Transplant Proc. 1997. PMID: 9365627 Clinical Trial. No abstract available.

3

Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients.

Kliem V, Petersen R, Ehlerding G, Schaumann D, Eisenberger U, Koch KM, Pichlmayr R, Brunkhorst R. Kliem V, et al. Among authors: schaumann d. Transplant Proc. 1998 Jun;30(4):1251-3. doi: 10.1016/s0041-1345(98)00231-0. Transplant Proc. 1998. PMID: 9636509 No abstract available.

4

Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study.

Haubitz M, Schellong S, Göbel U, Schurek HJ, Schaumann D, Koch KM, Brunkhorst R. Haubitz M, et al. Among authors: schaumann d. Arthritis Rheum. 1998 Oct;41(10):1835-44. doi: 10.1002/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q. Arthritis Rheum. 1998. PMID: 9778225 Clinical Trial.

5

[Lumbar spondylodiscitis caused by Salmonella enteritidis].

Schüler A, Schaumann D, Manns MP, Koch KM. Schüler A, et al. Among authors: schaumann d. Dtsch Med Wochenschr. 1994 Oct 14;119(41):1383-7. doi: 10.1055/s-2008-1058849. Dtsch Med Wochenschr. 1994. PMID: 7924947 Review. German.

6

[Cyclophosphamide bolus therapy in lupus nephritis--status of the clinical study].

Witte T, Schaumann D, Hein R, Neumann KH, Koch KM, Deicher H, Schmidt RE. Witte T, et al. Among authors: schaumann d. Immun Infekt. 1993 Apr;21 Suppl 1:24-6. Immun Infekt. 1993. PMID: 8344680 Clinical Trial. German.

7

[Cyclophosphamide bolus therapy in lupus nephritis].

Witte T, Schaumann D, Hein R, Helmchen U, Neumann KH, Koch KM, Deicher H, Schmidt RE. Witte T, et al. Among authors: schaumann d. Dtsch Med Wochenschr. 1993 Jul 16;118(27-28):1005-10. doi: 10.1055/s-2008-1059418. Dtsch Med Wochenschr. 1993. PMID: 8334946 Clinical Trial. German.

8

[Therapy of severe systemic lupus erythematosus].

Schmidt RE, Witte T, Deicher H, Neumann KH, Schaumann D, Koch KM. Schmidt RE, et al. Among authors: schaumann d. Dtsch Med Wochenschr. 1991 Dec 6;116(49):1891-3. Dtsch Med Wochenschr. 1991. PMID: 1743102 German. No abstract available.

9

Prospective cross-over comparisons of three low-density lipoprotein (LDL)-apheresis methods in patients with familial hypercholesterolaemia.

Schaumann D, Welch-Wichary M, Voss A, Schmidt H, Olbricht CJ. Schaumann D, et al. Eur J Clin Invest. 1996 Nov;26(11):1033-8. doi: 10.1046/j.1365-2362.1996.2320587.x. Eur J Clin Invest. 1996. PMID: 8957211 Clinical Trial.

10

Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitors.

Olbricht CJ, Schaumann D, Fischer D. Olbricht CJ, et al. Among authors: schaumann d. Lancet. 1992 Oct 10;340(8824):908-9. doi: 10.1016/0140-6736(92)93315-e. Lancet. 1992. PMID: 1357312 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters